Infection-control strategies for preventing the transmission of meticillin-resistant Staphylococcus aureus (MRSA) in nursing homes for older people (Review)

Background: Nursing homes for older people provide an environment likely to promote the acquisition and spread of meticillin-resistant Staphylococcus aureus (MRSA), putting residents at increased risk of colonisation and infection. It is recognised that infection control strategies are important in preventing and controlling MRSA transmission.

Objectives: The objective of this review was to determine the effects of infection control strategies for preventing the transmission of MRSA in nursing homes for older people.

Search strategy: We searched the Cochrane Central Register of Controlled Trials (CENTRAL, The Cochrane Library 2009, Issue 2), the Cochrane Wounds Group Specialised Register (searched May 29th, 2009). We also searched MEDLINE (from 1950 to May Week 4 2009), Ovid EMBASE (1980 to 2009 Week 21), EBSCO CINAHL (1982 to May Week 4 2009), British Nursing Index (1985 to May 2009), DARE (1992 to May 2009), Web of Science (1981 to May 2009), and the Health Technology Assessment (HTA) website (1988 to May 2009). Research in progress was sought through Current Clinical Trials (www.controlled-trials.com), Medical Research Council Research portfolio, and HSRPRoj (current USA projects). SIGLE was also searched in order to identify atypical material which was not accessible through more conventional sources.

Selection criteria: All randomised and controlled clinical trials, controlled before and after studies and interrupted time series studies of infection control interventions in nursing homes for older people were eligible for inclusion.

Data collection and analysis: Two authors independently reviewed the results of the searches.

Main results: Since no studies met the selection criteria, neither a meta-analysis nor a narrative description of studies was possible.

Authors' conclusions: The lack of studies in this field is surprising. Nursing homes for older people provide an environment likely to promote the acquisition and spread of infection, with observational studies repeatedly reporting that being a resident of a nursing home increases the risk of MRSA colonisation. Much of the evidence for recently-issued United Kingdom guidelines for the control and prevention of MRSA in health care facilities was generated in the acute care setting. It may not be possible to transfer such strategies directly to the nursing home environment, which serves as both a healthcare setting and a resident's home. Rigorous studies should be conducted in nursing homes, to test interventions that have been specifically designed for this unique environment.

Epidemiological analysis of methicillin-resistant Staphylococcus aureus isolates from adult patients with cystic fibrosis

Using pulsed-field gel electrophoresis, we genotyped 21 methicillin-resistant Staphylococcus aureus isolates from patients attending an adult cystic fibrosis unit. Eleven patients exhibited pulsotypes related to 2 locally endemic strains. Eleven chronically colonized patients were assessed over a period of up to 2 years, and all demonstrated a retention of strain type.

Antibiotic Management of Lung Infections in Cystic Fibrosis. I. The Microbiome, Methicillin-Resistant Staphylococcus aureus, Gram-Negative Bacteria, and Multiple Infections

Despite significant advances in treatment strategies targeting the underlying defect in cystic fibrosis (CF), airway infection remains an important cause of lung disease. In this two-part series, we review recent evidence related to the complexity of CF airway infection, explore data suggesting the relevance of individual microbial species, and discuss current and future treatment options. In Part I, the evidence with respect to the spectrum of bacteria present in the CF airway, known as the lung microbiome is discussed. Subsequently, the current approach to treat methicillin-resistant Staphylococcus aureus, gram-negative bacteria, as well as multiple coinfections is reviewed. Newer molecular techniques have demonstrated that the airway microbiome consists of a large number of microbes, and the balance between microbes, rather than the mere presence of a single species, may be relevant for disease pathophysiology. A better understanding of this complex environment could help define optimal treatment regimens that target pathogens without affecting others. Although relevance of these organisms is unclear, the pathologic consequences of methicillin-resistant S. aureus infection in patients with CF have been recently determined. New strategies for eradication and treatment of both acute and chronic infections are discussed. Pseudomonas aeruginosa plays a prominent role in CF lung disease, butmany other nonfermenting gram-negative bacteria are also found in the CF airway. Many new inhaled antibiotics specifically targeting P. aeruginosa have become available with the hope that they will improve the quality of life for patients. Part I concludes with a discussion of how best to treat patients with multiple coinfections.

Infection control strategies for preventing the transmission of meticillin-resistant Staphylococcus aureus (MRSA) in nursing homes for older people (Review)

Background: Nursing homes for older people provide an environment likely to promote the acquisition and spread of meticillin-resistant Staphylococcus aureus (MRSA), putting residents at increased risk of colonisation and infection. It is recognised that infection prevention and control strategies are important in preventing and controlling MRSA transmission.

Objectives: To determine the effects of infection prevention and control strategies for preventing the transmission of MRSA in nursing homes for older people.

Search methods: In August 2013, for this third update, we searched the Cochrane Wounds Group Specialised Register, the Cochrane Central Register of Controlled Trials (CENTRAL, The Cochrane Library), Database of Abstracts of Reviews of Effects (DARE, The Cochrane Library), Ovid MEDLINE, OVID MEDLINE (In-process and Other Non-Indexed Citations), Ovid EMBASE, EBSCO CINAHL, Web of Science and the Health Technology Assessment (HTA) website. Research in progress was sought through Current Clinical Trials, Gateway to Reseach, and HSRProj (Health Services Research Projects in Progress).

Selection criteria: All randomised and controlled clinical trials, controlled before and after studies and interrupted time series studies of infection prevention and control interventions in nursing homes for older people were eligible for inclusion.

Data collection and analysis: Two review authors independently reviewed the results of the searches. Another review author appraised identified papers and undertook data extraction which was checked by a second review author.

Main results: For this third update only one study was identified, therefore it was not possible to undertake a meta-analysis. A cluster randomised controlled trial in 32 nursing homes evaluated the effect of an infection control education and training programme on MRSA prevalence. The primary outcome was MRSA prevalence in residents and staff, and a change in infection control audit scores which measured adherence to infection control standards. At the end of the 12 month study, there was no change in MRSA prevalence between intervention and control sites, while mean infection control audit scores were significantly higher in the intervention homes compared with control homes.

Authors' conclusions: There is a lack of research evaluating the effects on MRSA transmission of infection prevention and control strategies in nursing homes. Rigorous studies should be conducted in nursing homes, involving residents and staff to test interventions that have been specifically designed for this unique environment.

Vergleichende Untersuchungen Methicillin-resistenter Staphylococcus aureus des Klinikums Kassel der Jahre 1999 bis 2004

Die vorliegende Arbeit liefert erstmals einen umfassenden Überblick über die molekulare Epidemiologie von Methicillin resistenten Staphylococcus aureus (MRSA) eines nordhessischen Krankenhauses inklusive seines Umfeldes und deren Entwicklung in einem Zeitraum von fünf Jahren. Von besonderer Bedeutung ist, dass die MRSA-Stämme hierfür nicht nur anhand ihrer SCCmec-Region (staphylococcal cassette chromosome) typisiert wurden, sondern eine weitergehende Charakterisierung auf Grund der Bestimmung des Vorkommens von Antibiotikaresistenz- und Toxingenen, sowie Plasmiden erfolgte. Dabei wurde ein neuer SCCmec-Typ entdeckt und charakterisiert und weitere noch unbekannte SCCmec-Elemente beschrieben. Bei der Charakterisierung der MRSA-Kollektive konnten bzgl. aller untersuchten Eigenschaften im Laufe der Zeit signifikante Veränderungen beobachtet werden. Am deutlichsten waren diese Unterschiede zwischen dem ältesten Kollektiv aus 1999 und allen nachfolgenden Kollektiven. Die Kollektive aus 2001, 2002, 2003 und 2004 zeigten untereinander größere Ähnlichkeiten, aber dennoch gleichzeitig eine tendenziell divergente Entwicklung einzelner Eigenschaften. Besonders auffallend war das dominante Auftreten von SCCmecIV mit 63-87% der Isolate eines Kollektivs ab 2001, gegenüber 16% in 1999. Weiterhin erfolgte eine markante Veränderung im Vorkommen einzelner Antibiotikaresistenzgene von 1999 bis 2004. So waren aacA-aphD und ermA bei MRSA aus 1999 mit 84% bzw. 90% deutlich häufiger als in allen Kollektiven der folgenden Jahre (aacA-aphD: max. 32%, ermA: max. 40%). Wohingegen ermC ein stets zunehmendes Vorkommen von 3% auf 67% über den Untersuchungszeitraum zeigte. Unkontinuierliches aber statistisch relevant vermehrtes Auftreten von tetM konnte bei Isolaten aus 1999 (40%) und 2004 (74%) nachgewiesen werden. Auch bei Toxingenen zeigten sich deutliche Unterschiede in der zeitlichen Verteilung. Ab 2001 zeigten alle Isolate wesentlich höhere Anteile an sec, seg und sei verglichen mit den MRSA aus 1999. So konnte sec im Kollektiv aus 1999 gar nicht nachgewiesen werden, in denen der Folgejahre mit 54-77%. Die Werte für seg und sei stiegen von 48% bzw. 41% in 1999 kontinuierlich auf über 90% in 2004. Die Häufigkeit von MRSA sowohl mit mehreren Resistenzgenen als auch die mit mehreren Toxingenen nahm im Laufe der Zeit zu und korrelierte mit dem Vorkommen von Plasmiden. Bezüglich seiner Korrelation mit den vorkommenden Plasmiden zeigte SCCmecIV im Erhebungszeitraum besonders deutlich eine Veränderung. So nahm über den Zeitraum der Beobachtung die Anzahl der Stämme die zusätzlich zu einem großen Plasmid ein weiteres kleines Plasmid besaßen signifikant zu. Auch beim Vergleich der SCCmec-Typen der MRSA-Isolate konnten Unterschiede bzgl. aller weiteren untersuchten Eigenschaften dargestellt werden. So zeigten z.B. alle SCCmecIIIA das sea-Gen, während dies bei allen anderen in der vorliegenden Arbeit untersuchten SCCmec-Typen nur vereinzelt vorkam. SCCmecII-Stämme wiesen sowohl die meisten Antibiotikaresistenz- als auch Toxingene auf. Es wurde ferner gezeigt, dass Stämme mit vielen Resistenzgenen auch eine hohe Anzahl Toxingene besaßen und dies im Zusammenhang mit einem erhöhten Plasmidgehalt stehen könnte. Aus den MRSA-Kollektiven isolierte Plasmide konnten aufgrund von Restriktionsanalysen als verwandt zu β-Laktamase-Plasmiden des Grundtyps pI524 und pI258 beschrieben werden. Der in vorliegender Arbeit gezeigte Zusammenhang zwischen der Anzahl von direct repeat units (dru) in der Hypervariablen Region (HVR) und dem SCCmec-Typ half den Unterschied zwischen SCCmecIV und SCCmecIVA, sowie die Sonderstellung des in vorliegender Arbeit erstmalig beschriebenen SCCmecIA/II darzustellen. Nicht alle Isolate konnten einem bekannten SCCmec-Typ zugeordnet werden, es handelt sich bei diesen Ausnahmen um weitere noch unbekannte und hier erstmalig beschriebene SCCmec-Typen. Aufgrund der vorliegenden Arbeit konnte ein neuer SCCmec-Typ definiert werden, namentlich der Typ SCCmecIA/II, der seit 1999 in der Region gehäuft vorkommt Die vorliegenden Untersuchungen zeigten somit, dass die Epidemiologie von MRSA der Region Nordhessen trotz bestehender Gemeinsamkeiten zur MRSA-Situation in ganz Deutschland auch Besonderheiten aufweist. Diese nun zu kennen kann einen Beitrag zur gezielten Verbesserung bisheriger Maßnahmen zur Ausbreitungskontrolle von MRSA in der nordhessischen Region leisten.

Evaluation of the antimicrobial susceptibility of methicillin-resistant Staphylococcus aureus isolated from human infections

Multiresistant Staphylococcus aureus constitutes an important public health problem, especially in view of its possible spread in nosocomial environments. In the present work, we analyzed the susceptibility profile of 80 S. aureus stains from human infections resistant to at least 10 drugs. For this study, the techniques used were the disk method and minimum inhibitory concentration (MIC) of the following drugs: cefuroxime, ciprofloxacin, clindamycin, erythromycin, gentamycin, imipenem, oxacillin, rifampicin, tetracycline and vancomycin, according the criteria of the National Committee for Clinical Laboratory Standards (NCCLS). Methicillin was included in the antibiogram as a marker, which is usually used in drugs selection for the treatment of staphylococcal infections. Results indicated that the most effective drug was vancomycin. For the other 10 drugs, the percentage of resistant strains ranged from 85% to 93.75%. In relation to the MICs, it was observed that vancomycin (MIC 90% = 0.615ug/ml) was the most effective drug; followed by rifampicin (MIC 90% = 2.6ug/ml) and ciprofloxacin (MIC 90% = 26.6ug/ml). The drugs that showed the least effective activity were cefuroxime, clindamycin, erythromycin, gentamycin, and oxacillin. On the other hand, observation of β-lactamase production revealed that most of the methicillin-resistant strains produced β-lactamase (83.7%), potentiating the risks of nosocomial infections. In general, vancomycin still continues to be one of the most effective drugs for staphylococcal infections therapy.

Comparative efficacy of trovafloxacin in experimental endocarditis caused by ciprofloxacin-sensitive, methicillin-resistant Staphylococcus aureus

The new fluoroquinolone trovafloxacin was tested against a ciprofloxacin-sensitive, methicillin-resistant Staphylococcus aureus strain in the rabbit model of endocarditis. Trovafloxacin was more effective than vancomycin (CFU/g of vegetation, 2.65 +/- 1.87 versus 4.54 +/- 2.80 [mean +/- standard deviation]; P < 0.05) or ampicillin-sulbactam plus rifampin (4.9 +/- 1.1 CFU/g). The addition of ampicillin-sulbactam to trovafloxacin tended to reduce titers further.

Acquisition of a natural resistance gene renders a clinical strain of methicillin-resistant Staphylococcus aureus resistant to the synthetic antibiotic linezolid.

Linezolid, which targets the ribosome, is a new synthetic antibiotic that is used for treatment of infections caused by Gram-positive pathogens. Clinical resistance to linezolid, so far, has been developing only slowly and has involved exclusively target site mutations. We have discovered that linezolid resistance in a methicillin-resistant Staphylococcus aureus hospital strain from Colombia is determined by the presence of the cfr gene whose product, Cfr methyltransferase, modifies adenosine at position 2503 in 23S rRNA in the large ribosomal subunit. The molecular model of the linezolid-ribosome complex reveals localization of A2503 within the drug binding site. The natural function of cfr likely involves protection against natural antibiotics whose site of action overlaps that of linezolid. In the chromosome of the clinical strain, cfr is linked to ermB, a gene responsible for dimethylation of A2058 in 23S rRNA. Coexpression of these two genes confers resistance to all the clinically relevant antibiotics that target the large ribosomal subunit. The association of the ermB/cfr operon with transposon and plasmid genetic elements indicates its possible mobile nature. This is the first example of clinical resistance to the synthetic drug linezolid which involves a natural resistance gene with the capability of disseminating among Gram-positive pathogenic strains.